Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids
Journal of Medical Virology · 2026-11 · 98 (11)
DOI: 10.1002/jmv.71201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 30.10.2026. Verfasst von Ingrid Fricke-Galindo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico. Hauptthemen laut MEDLINE: Interleukin-10, Adrenal Cortex Hormones, COVID-19, COVID-19 Drug Treatment. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We aimed to evaluate the association between IL10 variants and plasma IL‐10 levels and clinical outcomes in patients with severe COVID‐19 treated with corticosteroids. We studied 944 patients with severe COVID‐19 who were treated with corticosteroids. The clinical outcomes evaluated were in‐hospital mortality and the requirement of invasive mechanical ventilation (IMV). The variants IL10 rs1800872, rs1554286, rs3024505, and rs3122605 were determined using TaqMan SNP assays, and IL‐10 levels were measured by ELISA at the start of corticosteroid treatment (T1) and after 8 days (T2). The rs1800872‐TT ( p = 0.035, OR = 1.55, 95% CI = 1.03–2.33) and the rs1554286‐AA genotypes were associated with IMV ( p adj = 0.036, OR = 2.42, 95% CI = 1.12–5.95). IL‐10 levels were higher at T1 than at T2. At T2, IL‐10 levels were higher in non‐survivors (15.9 vs. 7.0 pg/mL, p < 0.001) and in patients requiring IMV (9.9 vs. 5.5 pg/mL, p < 0.001). Among non‐survivors, IL‐10 plasma levels did not decrease at T2. The alluvial plot revealed that 51.9% of patients in the highest IL‐10 tertile at T1 remained in the highest tertile at T2, with a mortality rate of 50%. IL10 rs1800872 and rs1554286 contribute to the risk of requiring IMV. Elevated IL‐10 levels after corticosteroid treatment were linked to in‐hospital mortality and IMV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.
- Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
- Subdirección de Investigación Clínica, Instituto Nacional de Cardiología Ignacio Chávez, México City, Mexico.
- Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa, Culiacán Rosales, Sinaloa, Mexico.
- Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
ORCID-Profile: Ingrid Fricke-Galindo, Francisco M Ortega-Villafuerte, Gloria Pérez-Rubio, Ivette Buendía-Roldán, Julián Ramírez-Bello, Azael A Castillo Morales, Leslie Chávez-Galán, Rafael de Jesús Hernández-Zenteno, Espiridión Ramos-Martínez, Salvador García-Carmona, Daniela Josefina Cataneo-Piña, Nora Edith Bautista-Félix, Ramcés Falfán-Valencia
Zitieren
APA
Fricke-Galindo, I., Ortega-Villafuerte, F. M., Pérez-Rubio, G., Buendía-Roldán, I., Ramírez-Bello, J., Castillo Morales, A. A., Chávez-Galán, L., de Jesús Hernández-Zenteno, R., Ramos-Martínez, E., García-Carmona, S., Cataneo-Piña, D. J., Bautista-Félix, N. E., & Falfán-Valencia, R. (2026). Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids. Journal of Medical Virology, 98(11). https://doi.org/10.1002/jmv.71201
Vancouver
Fricke-Galindo I, Ortega-Villafuerte FM, Pérez-Rubio G, Buendía-Roldán I, Ramírez-Bello J, Castillo Morales AA, et al. Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids. Journal of Medical Virology. 2026;98(11). doi:10.1002/jmv.71201
BibTeX
@article{FrickeGalindo2026,
author = {Fricke-Galindo, Ingrid and Ortega-Villafuerte, Francisco M and Pérez-Rubio, Gloria and Buendía-Roldán, Ivette and Ramírez-Bello, Julián and Castillo Morales, Azael A and Chávez-Galán, Leslie and de Jesús Hernández-Zenteno, Rafael and Ramos-Martínez, Espiridión and García-Carmona, Salvador and Cataneo-Piña, Daniela Josefina and Bautista-Félix, Nora Edith and Falfán-Valencia, Ramcés},
title = {Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {11},
doi = {10.1002/jmv.71201}
}
EUVIMED